Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effect of Low Protein Diet on Top of Dapagliflozin on Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus
Sponsor: Anemia Working Group Romania
Summary
This is a prospective multicenter randomized controlled trial with a total duration of 36 months aiming to evaluate the effectiveness and the safety of low protein diet on top of sodium-glucose cotransporter 2 inhibitors (SGLT2i) and renin-angiotensin-aldosterone inhibitors (RAASi) in reducing the progression of chronic kidney disease in patients with type 2 Diabetes Mellitus
Official title: Effect of the Low PROtein Diet on Top of DAPAgliflozin and RAASi on the Progression of Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
200
Start Date
2022-01-01
Completion Date
2027-12-31
Last Updated
2026-10-28
Healthy Volunteers
No
Interventions
Dapagliflozin 10 mg Tab
Dapagliflozin 10 mg once daily
Low protein diet
Plant based low protein diet (0.6 g/kg IBW)
Locations (1)
Carol Davila University of Medicine and Pharmacy Bucharest
Bucharest, Romania